NeuPath Health, Inc. (NPTH.V)
0.45
0.00 (0.00%)
CAD |
TSXV |
Feb 11, 16:00
NeuPath Health EPS Diluted (Quarterly) : -0.0027 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Innovotech, Inc. | 0.0018 |
| Cannara Biotech, Inc. | 0.0108 |
| Medexus Pharmaceuticals, Inc. | -0.0134 |
| Arch Biopartners, Inc. | -0.0041 |
| Biocure Technology, Inc. | -0.0029 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.094M |
| Revenue (Quarterly) | 22.08M |
| Total Expenses (Quarterly) | 22.23M |
| Enterprise Value | 34.38M |
| Gross Profit Margin (Quarterly) | 16.55% |
| Profit Margin (Quarterly) | -0.43% |
| Earnings Yield | -2.22% |
| Operating Earnings Yield | 9.07% |
| Normalized Earnings Yield | 1.089 |